Investor Presentaiton
2022 H2 outlook: Hong Kong IPO market
Global geopolitical, economic uncertainties and the ongoing
pandemic, however, will continue to sully sentiment for the
rest of the year in Hong Kong. Momentum is expected to
pick up gradually as these uncertainties fade out,
fuelled by the solid IPO pipeline as more than 170
applicants continue to wait to list on the city's bourse.
In order to encourage the listing of specialist technology
companies, authorities in Hong Kong are now reviewing the
listing rules and considering whether to revise the listing
requirements. More details on this matter are expected to be
announced during the second half of the year.
Despite the challenging funding
environment and global market
uncertainties, businesses across
different sectors continue to purse
major digital transformation and
decarbonisation initiatives. Such
demands are creating opportunities for
companies involved in digital and
sustainable/renewable technologies
which would be attractive to strategic
and corporate investors.
"
Homecoming and life science listings would remain the
key focus, as Hong Kong continues to be the natural choice
for homecoming listings, and with the relentless development
for biotech fund-raising and investment ecosystem in the
bourse.
Irene Chu
Partner
Head of New Economy and Life Sciences
KPMG China
KPMG
© 2022 KPMG, a Hong Kong (SAR) partnership and a member firm of the KPMG global organisation of
independent member firms affiliated with KPMG International Limited, a private English company limited
by guarantee. All rights reserved. Printed in Hong Kong (SAR).
Mainland China and Hong Kong IPO markets
19View entire presentation